Bombesin, which releases NT from the gut in dogs and man, also releases NT from rat MTC. The selective inhibition of NT release with STS suggests that BBS and CaCl2 may act by different mechanisms. This model provides unique opportunities for study of the synthesis, storage, and release of NT. BBS-stimulated NT release may be a useful clinical marker for patients with MTC.
|Original language||English (US)|
|Number of pages||2|
|State||Published - Jan 1 1984|
ASJC Scopus subject areas